Patents by Inventor Suk-Won Yoon
Suk-Won Yoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240076182Abstract: An operating method is disclosed for a dehydrogenation reaction system. The method includes providing a system having: an acid aqueous solution tank including an acid aqueous solution; a dehydrogenation reactor including a chemical hydride of a solid state and receiving an acid aqueous solution from the acid aqueous solution tank to react the chemical hydride with the acid aqueous solution to generate hydrogen; and a fuel cell stack receiving hydrogen generated from the dehydrogenation reactor to be reacted with oxygen to generate water and simultaneously to generate electrical energy. The method also includes recycling the water generated from the fuel cell stack to one or all of the acid aqueous solution tank, the dehydrogenation reactor, and a separate water tank. The acid is formic acid and, in in the dehydrogenation reactor, the temperature is in a range of 10° C. to 400° C. and the pressure is in a range of 1 bar to 100 bar.Type: ApplicationFiled: November 7, 2023Publication date: March 7, 2024Applicants: HYUNDAI MOTOR COMPANY, KIA CORPORATION, KOREA INSTITUTE OF SCIENCE AND TECHNOLOGYInventors: Pyung Soon Kim, Jin Woo Choung, Jihui Seo, Suk Woo Nam, Young Suk Jo, Hyangsoo Jeong, Jaewon Kirk, Chang Won Yoon, Yongmin Kim
-
Patent number: 8513277Abstract: The present invention provides novel pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.Type: GrantFiled: November 15, 2011Date of Patent: August 20, 2013Assignee: Yuhan CorporationInventors: Jae-Gyu Kim, Byung-Nak Ahn, Hyouk-Woo Lee, Suk-Won Yoon, Young-Ae Yoon, Dong-Hoon Kim, Se-Hoon Keum, Young-Ah Shin, Heui Il Kang, Sun-Young Jang
-
Patent number: 8188114Abstract: The present invention provides novel pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.Type: GrantFiled: November 6, 2009Date of Patent: May 29, 2012Assignee: Yuhan CorporationInventors: Jae-Gyu Kim, Byung-Nak Ahn, Hyouk-Woo Lee, Suk-Won Yoon, Young-Ae Yoon, Dong-Hoon Kim, Chan-Sun Park, Seok-Hee Han, Myung-Hun Cha, Heui II Kang, Sun-Young Jang
-
Patent number: 8148529Abstract: The present invention provides novel pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.Type: GrantFiled: September 3, 2005Date of Patent: April 3, 2012Assignee: Yuhan CorporationInventors: Jae-Gyu Kim, Byung-Nak Ahn, Hyouk-Woo Lee, Suk-Won Yoon, Young-Ae Yoon, Dong-Hoon Kim, Se-Hoon Keum, Young-Ah Shin, Heui Il Kang, Ryong Choi, Sun-Young Jang, legal representative
-
Publication number: 20120065224Abstract: The present invention provides novel pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.Type: ApplicationFiled: November 15, 2011Publication date: March 15, 2012Applicant: YUHAN CORPORATIONInventors: Jae-Gyu KIM, Byung-Nak AHN, Hyouk-Woo LEE, Suk-Won YOON, Young-Ae YOON, Dong-Hoon KIM, Se-Hoon KEUM, Young-Ah SHIN, Heui-Il KANG, Ryong CHOI, Sun-Young JANG
-
Publication number: 20100069430Abstract: The present invention provides novel pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.Type: ApplicationFiled: November 6, 2009Publication date: March 18, 2010Applicant: Yuhan CorporationInventors: Jae-Gyu KIM, Byung-Nak Ahn, Hyouk-Woo Lee, Suk-Won Yoon, Young-Ae Yoon, Dong-Hoon Kim, Chan-Sun Park, Seok-Hee Han, Myung-Hun Cha, Heui-II Kang, Sun-Young Jang
-
Patent number: 7662832Abstract: The present invention provides novel pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.Type: GrantFiled: September 3, 2005Date of Patent: February 16, 2010Assignee: Yuhan CorporationInventors: Jae-Gyu Kim, Byung-Nak Ahn, Hyouk-Woo Lee, Suk-Won Yoon, Young-Ae Yoon, Dong-Hoon Kim, Chan-Sun Park, Seok-Hee Han, Myung-Hun Cha, Heui-Il Kang, Sun-Young Jang
-
Patent number: 7642269Abstract: The present invention provides novel pyrrolo[3,2-b]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[3,2-b]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.Type: GrantFiled: September 3, 2005Date of Patent: January 5, 2010Assignee: Yuhan CorporationInventors: Jae-Gyu Kim, Byung-Nak Ahn, Hyouk-Woo Lee, Suk-Won Yoon, Young-Ae Yoon, Choong-Hyun Lee, Myung-Hun Cha, Heui-Il Kang, Sun-Young Jang
-
Patent number: 7541366Abstract: The present invention provides novel pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.Type: GrantFiled: September 3, 2005Date of Patent: June 2, 2009Assignee: YUHAN CorporationInventors: Jae-Gyu Kim, Byung-Nak Ahn, Hyouk-Woo Lee, Suk-Won Yoon, Young-Ae Yoon, Hyun-Ho Choi, Heui-Il Kang
-
Publication number: 20090005409Abstract: The present invention provides novel pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.Type: ApplicationFiled: September 3, 2005Publication date: January 1, 2009Applicant: YUHAN CORPORATIONInventors: Jae-Gyu Kim, Byung-Nak Ahn, Hyouk-Woo Lee, Suk-Won Yoon, Young-Ae Yoon, Dong-Hoon Kim, Se-Hoon Keum, Young-Ah Shin, Heui Il Kang, Ryong Choi, Sun-Young Jang
-
Publication number: 20070249658Abstract: The present invention provides novel pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[3,2-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.Type: ApplicationFiled: September 3, 2005Publication date: October 25, 2007Applicant: YUHAN CORPORATIONInventors: Jae-Gyu Kim, Byung-Nak Ahn, Hyouk-Woo Lee, Suk-Won Yoon, Young-Ae Yoon, Hyun-Ho Choi, Heui-Il Kang
-
Publication number: 20070219230Abstract: The present invention provides novel pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[2,3-c]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.Type: ApplicationFiled: September 3, 2005Publication date: September 20, 2007Inventors: Jae-Gyu Kim, Byung-Nak Ahn, Hyouk-Woo Lee, Suk-Won Yoon, Young-Ae Yoon, Dong-Hoon Kim, Chan-Sun Park, Seok-Hee Han, Myung-Hun Cha, Heui-Il Kang
-
Publication number: 20070213358Abstract: The present invention provides novel pyrrolo[3,2-b]pyridine derivatives or pharmaceutically acceptable salts thereof, processes for the preparation thereof, and compositions comprising the same. The pyrrolo[3,2-b]pyridine derivatives or pharmaceutically acceptable salts thereof of the present invention have excellent proton pump inhibition effects and possess the ability to attain a reversible proton pump inhibitory effect.Type: ApplicationFiled: September 3, 2005Publication date: September 13, 2007Applicant: YUHAN CORPORATIONInventors: Jae-Gyu Kim, Byung-Nak Ahn, Hyouk-Woo Lee, Suk-Won Yoon, Young-Ae Yoon, Choong-Hyun Lee, Myung-Hun Cha, Heui-Il Kang, Sun-Young Jang
-
Publication number: 20020045218Abstract: The present invention relates to a recombinant expression vector containing a fusion gene which is prepared by ligating adhesion gene of H. pylori and A2 and B subunit genes of Vibrio cholerae toxin, and a process for preparing a chimeric protein employing a recombinant microorganism transformed with the said expression vector. The recombinant DNA which is designed for convenient expression and gene manipulation, may express a chimeric protein having excellent immunogenicity to H. pylori, which is stable in stomach, and penetrate mucous membrane of stomach easily, finally to stimulate production of sIgA. Accordingly, the chimeric protein expressed from the recombinant DNA may be used as an active ingredient of the diagnostic kit for H. pylori infection and preventive or therapeutic vaccine for H. pylori-associated diseases, and may be used in the production of anti-H. pylori antibody.Type: ApplicationFiled: January 11, 2001Publication date: April 18, 2002Applicant: BIOPHARM INC.Inventors: Byung-O Kim, Byoung-Kwang Lee, Suk-Won Yoon, Seung-Kook Park, Young-Hyo Yu